Allantoin

Identification

Name
Allantoin
Accession Number
DB11100
Type
Small Molecule
Groups
Approved
Description

Allantoin is a substance that is endogenous to the human body and also found as a normal component of human diets [FDA Label]. In healthy human volunteers, the mean plasma concentration of allantoin is about 2-3 mg/l. During exercise, the plasma allantoin concentration rapidly increases about two fold and remains elevated [FDA Label]. In human muscle, urate is oxidized to allantoin during such exercise [FDA Label]. The concentration of allantoin in muscles increases from a resting value of about 5000 ug/kg to about 16000 ug/kg immediately after short-term exhaustive cycling exercise [FDA Label].

More specifically, allantoin is a diureide of glyoxylic acid that is produced from uric acid. It is a major metabolic intermediate in most organisms. Allantoin is found in OTC cosmetic products and other commercial products such as oral hygiene products, in shampoos, lipsticks, anti-acne products, sun care products, and clarifying lotions [4]. Allantoin has also demonstrated to ameliorate the wound healing process in some studies [1].

Structure
Thumb
Synonyms
  • (2,5-Dioxo-4-imidazolidinyl)urea
  • 2,5-Dioxo-4-imidazolidinyl-urea
  • 4-ureido-2,5-imidazolidinedione
  • 5-Ureido-2,4-imidazolidindione
  • 5-Ureidohydantoin
  • 5-ureidohydantoin
  • glyoxyldiureide
  • N-(2,5-Dioxo-4-imidazolidinyl)urea
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Elta Dermal Gel for Wound DressingGel2 %TopicalSwiss American ProductsNot applicableNot applicableCanada
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
12 Hour HealingOintment.5 g/100gTopicalSkinfix, Inc.2017-05-02Not applicableUs
12 Hour MiracleOintment.5 g/100gTopicalSkinfix, Inc.2015-05-23Not applicableUs
AAFX HairSolution.02 mg/71TopicalProstemics Co., Ltd.2014-12-01Not applicableUs
AAFX SkinSolution.02 mg/71TopicalProstemics Co., Ltd.2014-12-01Not applicableUs
AAPE Hair AmpouleSolution.03 mg/61TopicalProstemics Co., Ltd.2014-08-01Not applicableUs
AAPE Skin AmpouleSolution.03 mg/61TopicalProstemics Co., Ltd.2014-08-01Not applicableUs
Actifirm Recovery Eye Gowoonsesang ExpertCream.1 mL/20mLCutaneousGOWOONSESANG COSMETICS CO., LTD.2010-06-012018-02-24Us
AllantoinAerosol, spray.425 g/85gTopicalPremier Brands of America Inc.2018-03-27Not applicableUs
AllantoinAerosol, spray.425 g/85gTopicalKroger2018-02-12Not applicableUs
AllantoinSpray.425 g/85gTopicalHarmon Store Inc.2015-09-04Not applicableUs
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
3M Nexcare Cold Sore TreatmentAllantoin (10 mg/g) + Benzocaine (50 mg/g)OintmentTopical3 M Pharmaceuticals2008-02-20Not applicableUs
4JointzAllantoin (.025 g/100g) + Eucalyptus oil (4 g/100g) + Tannic acid (5 g/100g)CreamTopicalArp(usa) Pty Ltd2017-01-312018-04-07Us
Actinac PwrAllantoin (24 mg) + Chloramphenicol (40 mg) + Hydrocortisone acetate (40 mg) + Nicoboxil (24 mg) + Sulfur (320 mg)PowderTopicalRoussel Canada Inc.1978-12-311996-09-09Canada
Actinac PwsAllantoin (24 mg) + Chloramphenicol (40 mg) + Hydrocortisone acetate (40 mg) + Nicoboxil (24 mg) + Sulfur (320 mg)Powder, for solutionTopicalHoechst Roussel Canada Inc.1994-12-312001-07-20Canada
AL0040600 Alba Cooling Aloe Burn ReliefAllantoin (.5 g/100g) + Menthol (.5 g/100g)SprayTopicalThe Hain Celestial Group2016-01-13Not applicableUs
Allegra Cooling Relief Anti-ItchAllantoin (.5 g/100g) + Diphenhydramine hydrochloride (2 g/100g)CreamTopicalChattem, Inc.2012-12-01Not applicableUs
Allegra Intensive Relief Anti-ItchAllantoin (.5 g/100g) + Diphenhydramine hydrochloride (2 g/100g)CreamTopicalChattem, Inc.2012-12-01Not applicableUs
Alphosyl CreamAllantoin (2 %) + Coal tar (5.4 %)CreamTopicalReed & Carnrick, Division Of Block Drug Company (Canada) Ltd.1961-12-311999-07-05Canada
Alphosyl LotionAllantoin (2 %) + Coal tar (5 %)LotionTopicalReed & Carnrick, Division Of Block Drug Company (Canada) Ltd.1958-12-311999-07-05Canada
Anbesol Cold Sore TherapyAllantoin (10 mg/g) + Benzocaine (200 mg/g) + Camphor (30 mg/g) + Petrolatum (649 mg/g)OintmentTopicalWyeth Consumer Healthcare Llc2006-05-09Not applicableUs
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
28 Remedy Aqua Brightening PeelingAllantoin (.05 g/100mL)GelTopicalNo Ts Co.,Ltd2016-01-02Not applicableUs
3ce Fixer and Mascara BlackAllantoin (.006 g/6.6g)LiquidTopicalNanda Co., Ltd.2016-08-20Not applicableUs
3ce Fixer and Mascara BrownAllantoin (.006 g/6.6g)LiquidTopicalNanda Co., Ltd.2016-08-20Not applicableUs
A.H.c Cotton 100 Mask Multi PeptideAllantoin (.025 g/25mL) + Adenosine (.01 g/25mL) + Nicotinamide (.05 g/25mL)PatchTopicalCarver Korea Co.,Ltd.2017-09-20Not applicableUs
A.H.c Cotton 100 Mask Skin CeramideAllantoin (.025 g/25mL) + Adenosine (.01 g/25mL) + Nicotinamide (.05 g/25mL)PatchTopicalCarver Korea Co.,Ltd.2017-09-05Not applicableUs
A.H.c Cotton 100 Mask Soy IsoflavoneAllantoin (.025 g/25mL) + Adenosine (.01 g/25mL) + Nicotinamide (.05 g/25mL)PatchTopicalCarver Korea Co.,Ltd.2017-09-14Not applicableUs
A.H.c Cotton 100 Mask Triple HyaluronicAllantoin (.025 g/25mL) + Adenosine (.01 g/25mL) + Nicotinamide (.05 g/25mL)PatchTopicalCarver Korea Co.,Ltd.2017-09-20Not applicableUs
AC Control SerumAllantoin (.1 g/50mL)CreamTopicalMiguhara2016-01-02Not applicableUs
Ahc Radiance Gommage PeelingAllantoin (1 g/100mL) + Dexpanthenol (1 g/100mL)GelTopicalCarver Korea Co.,Ltd.2017-05-10Not applicableUs
Alegria NeoAllantoin (.008 g/20g) + Silicon dioxide (2.8 g/20g)Paste, dentifriceTopicalSeowangmo Corporation2017-10-01Not applicableUs
Categories
UNII
344S277G0Z
CAS number
97-59-6
Weight
Average: 158.1154
Monoisotopic: 158.043990078
Chemical Formula
C4H6N4O3
InChI Key
POJWUDADGALRAB-UHFFFAOYSA-N
InChI
InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11)
IUPAC Name
(2,5-dioxoimidazolidin-4-yl)urea
SMILES
NC(=O)NC1NC(=O)NC1=O

Pharmacology

Indication

Allantoin is commonly applied in a variety of topical vehicles or applications such as cosmetic creams, toothpastes, mouthwashes, shampoos, lipsticks, anti-acne products, and lotions [4] for the purpose of moisturizing skin, enhancing the smoothness of skin, stimulating the healing of wounds, and soothing irritated skin [4].

Structured Indications
Not Available
Pharmacodynamics

There is no well controlled and appropriate data that can formally substantiate the pharmacodynamic properties of allantoin [FDA Label]. Nevertheless, ongoing studies suggest that allantoin possesses moisturizing and keratolytic effects, as well as abilities to increase the water content of the extracellular matrix and enhance the desquamation of upper layers of dead skin cells, all of which are activities that can promote cell proliferation and facilitate wound healing [1].

Mechanism of action

There is no well controlled data that can formally substantiate the method of action [FDA Label]. However, ongoing studies suggest that there may exist a histological wound healing profile induced by allantoin in rats that leads to the amelioration and fastening of the reestablishment of normal skin [1]. This facilitation of wound healing is supported by observations that wounds inflicted to rat subjects to which topical allantoin preparations were applied histologically demonstrated increased vasodilation, presence of inflammatory exudates, number of inflammatory cells, angiogenesis, fibroblast proliferation, and increased collagen deposition when compared to rat subjects with wounds that did not receive any allantoin administration [1].

Absorption

In studies on human subjects, a recovery of 19% and 34% of allantoin in the urine was observed but only in two individuals and only after the administration of massive doses of allantoin [5]. After intravenous administration, recovery in the urine was practically quantitative with doses of 75 to 600 mgm in the human model [5]. After 240 mgm, excretion continued for 72 hours in human subjects and the results were similar in regards to subcutaneous injection [5].

Volume of distribution
Not Available
Protein binding
Not Available
Metabolism

Uricase is the enzyme that possesses the functionality to convert uric acid to allantoin. Considering humans do not possess any endogenous uricase, uric acid is the only final breakdown product in the purine degradation of unwanted waste product purine nucleotides [5]. The presence of allantoin in human urine is subsequently the result of non-enzymatic processes on uric acid with reactive oxygen species [3]. Such non-enzymatic processes are consequently potentially suitable biomarkers for measuring oxidative stress in chronic illnesses and aging [3]. Furthermore, as allantoin is found endogenously and is part of basic, natural metabolic pathways, no accumulation is expected of it [FDA Label]. Additionally, allantoin is not believed to be metabolized to a measurable extent in humans and animals [FDA Label].

Route of elimination

Urinary clearance is the predominant excretion route [FDA Label].

Half life

When studied in cattle, sheep, and horses, the half-life of allantoin is in the range of 1 to 2.5 hours [FDA Label].

Clearance

Some studies suggest that the average renal clearance of allantoin in normal, healthy human subjects is approximately 123 cc per minute [2]. It is generally agreed upon that exogenously administered allantoin is rapidly excreted [FDA Label].

Toxicity

No studies on repeated dose toxicity and reproductive toxicity have been submitted. Moreover, studies show that the tumor incidence in allantoin treated animals did not differ largely from that found in untreated controls. As a result, further or additional toxicity, mutagenicity, or carcinogenicity tests are not required in view of the endogenous nature of allantoin and the general lack of overall toxicity [FDA Label].

Finally, as allantoin is a normal component of the diet in humans and is a substance of endogenous origin present in the body of humans, it is generally recognized as being a safe substance for humans [FDA Label].

Affected organisms
  • Humans and other mammals
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
  1. Araujo LU, Grabe-Guimaraes A, Mosqueira VC, Carneiro CM, Silva-Barcellos NM: Profile of wound healing process induced by allantoin. Acta Cir Bras. 2010 Oct;25(5):460-6. [PubMed:20877959]
  2. FRIEDMAN M, MYERS SO, ABRAHM PM: Allantoin clearance as a measure of glomerular filtration rate in man. Proc Soc Exp Biol Med. 1947 Dec;66(3):522. [PubMed:18900011]
  3. Kand'ar R, Zakova P: Allantoin as a marker of oxidative stress in human erythrocytes. Clin Chem Lab Med. 2008;46(9):1270-4. doi: 10.1515/CCLM.2008.244. [PubMed:18636793]
  4. Thornfeldt C: Cosmeceuticals containing herbs: fact, fiction, and future. Dermatol Surg. 2005 Jul;31(7 Pt 2):873-80; discussion 880. [PubMed:16029681]
  5. Toxnet Toxicology Data Network: Allantoin [Link]
External Links
Human Metabolome Database
HMDB0000462
KEGG Drug
D00121
KEGG Compound
C01551
PubChem Substance
347911116
ChemSpider
199
ChEBI
15676
ChEMBL
CHEMBL593429
Wikipedia
Allantoin
AHFS Codes
  • 84:24.12 — Basic Ointments and Protectants
  • 92:01.00* — Herbs and Natural Products
FDA label
Download (115 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedTreatmentEpidermolysis Bullosa1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
OintmentTopical.5 g/100g
LiquidTopical.006 g/6.6g
SolutionTopical.02 mg/71
SolutionTopical.03 mg/61
CreamTopical.1 g/50mL
CreamCutaneous.1 mL/20mL
Powder, for solutionTopical
Paste, dentifriceTopical
Aerosol, sprayTopical.425 g/85g
SprayTopical.425 g/85g
CreamTopical
GelTopical.5 g/100mL
GelTopical.15 g/30mL
CreamTopical.0005 g/mL
CreamTopical.8 mg/160mL
LotionTopical.8 mg/160mL
GelTopical.8 mg/160mL
ShampooTopical1.5 mg/300mL
SolutionTopical.005 mg/181
SprayTopical
LotionTopical.4 mL/200mL
LiquidTopical.004 mL/2mL
LiquidTopical.5 g/100g
PatchTopical.12 g/60g
ElixirTopical
EmulsionTopical0.6 %
LotionTopical.25 g/250g
LiquidTopical
CreamCutaneous.2 g/40g
PatchTopical.15 g/31
GelTopical.15 g/31
PatchTopical.004 g/2.4g
EmulsionTopical.1 g/100mL
PatchTopical.2 g/40g
LiquidTopical.0005 g/mL
SalveTopical5 mg/g
LiquidTopical.15 g/100mL
GelTopical.75 g/75g
CreamTopical.225 mg/45mL
SprayTopical.6 mg/120mL
CreamTopical.22 mg/45mL
CreamTopical2 g/100g
PatchTopical.5 1/25g
PatchTopical.06 g/51
LiquidTopical.1 g/100mL
CreamTopical.5 mg/100g
CreamTopical5 mg/g
JellyTopical.5 g/100mL
LotionTopical.5 g/100mL
CreamTopical50 mg/5g
LipstickTopical
CreamTopical.5 mL/100mL
CreamTopical.5 g/100mL
OintmentTopical
PowderTopical.02 g/50g
CreamTopical.5 g/100g
DiscTopical
Paste, dentifriceDental
EmulsionTopical
CreamTopical3.6 mL/60mL
LotionTopical.5 1/50mL
CreamTopical.5 mg/100mL
GelTopical.05 g/100g
LiquidTopical.02 g/100mL
CreamTopical.1 g/100g
LiquidTopical.05 g/100mL
LiquidTopical.2 g/100mL
CreamCutaneous
PatchTopical.1 g/49g
ShampooTopical6 g/300mL
LotionTopical
LotionTopical.75 mg/150mL
GelTopical2 %
LotionTopical2 %
GelTopical.1 g/100mL
CreamTopical1 g/50g
SprayTopical.3 g/60g
SprayTopical1.2 g/100g
Tablet, solubleTopical.5 mg/100mg
LiquidTopical.19 g/100g
CreamTopical.1 g/100mL
PowderTopical.44 mg/80mL
PowderTopical.055 g/10g
GelTopical.8 g/100g
LotionTopical.4 g/20mL
SoapTopical2 g/100g
LiquidTopical.54 mg/90mL
SolutionTopical.96 g/120mL
SolutionTopical.96 mg/120mL
SolutionTopical
LiquidTopical.1 g/10g
GelTopical.5 g/100g
OintmentTopical.02 g/g
SolutionTopical.04 g/5g
LotionTopical3 g/600g
LotionCutaneous.1 mL/20mL
SoapCutaneous; Topical5 mg/g
PowderTopical.002 g/g
SolutionTopical.25 g/205g
TabletVaginal.2 1/1
TabletVaginal66 mg/600mg
GelTopical51 mg/10mL
GelTopical50 mg/10mL
CreamTopical.67 mg/135mL
CreamTopical.25 mg/50mL
PatchTopical.2 g/100g
CreamTopical1 g/100mL
GelTopical10 mg/mL
GelTopical.1 mg/mL
TabletVaginal.11 1/600mg
StickTopical
LotionTopical0.55 %
PatchTopical.17 mg/35mL
LiquidTopical.01 g/100mL
OintmentTopical1 %
GelTopical
CreamTopical.075 g/15mL
LiquidTopical1 mg/30mL
LiquidTopical.08 g/100mL
LiquidTopical.75 mg/150mL
PatchTopical.028 g/28g
SprayTopical.3 mg/60mL
LiquidTopical.6 mg/30mL
LiquidTopical.54 mg/30mL
SoapTopical.55 g/110g
GelTopical3 mg/mL
LiquidTopical.05 g/10mL
ShampooTopical.75 g/150mL
SolutionTopical.3 g/60mL
LiquidTopical.025 g/5mL
SoapTopical1.3 g/100g
Aerosol, foamTopical1.25 mg/250mL
OilTopical.75 mg/150mL
SoapTopical.6 g/100g
GelTopical5 mg/g
SolutionTopical.1 g/100mL
LiquidTopical.002 g/mL
EmulsionTopical.002 g/mL
LiquidTopical2 g/100mL
LotionTopical.1 mL/50mL
LiquidTopical.02 mg/mL
LiquidTopical.1 g/100g
PowderTopical.007 g/.7g
LiquidTopical1 g/100mL
GelTopical.05 g/100mL
CreamTopical.25 g/50g
ShampooTopical.75 mg/150mL
SolutionTopical.3 mg/60mL
LiquidTopical.025 mg/5mL
LiquidTopical.3 g/100mL
SolutionTopical.175 mg/51
PatchTopical.16 g/32g
LotionTopical.1 g/100mL
PatchTopical.015 mg/101
SprayTopical.1 g/100mL
SprayTopical.36 mg/60mL
StickTopical.5 g/100g
CreamTopical.0125 mg/25g
CreamTopical.004 mg/20mL
CreamTopical.0042 mg/21mL
SoapTopical.05 g/100g
StickTopical5 mg/g
CreamTopical5 mg/100mL
LotionTopical.5 mL/100mL
CreamTopical5 mg/mL
CreamTopical.005 mg/g
GelTopical10 mg/g
CreamTopical1.5 g/300g
LiquidTopical.48 mg/80mL
SolutionTopical.48 mg/80mL
CreamTopical.2 g/100mL
EmulsionTopical.02 g/100mL
CreamTopical.02 g/100mL
CreamTopical10 mg/g
SoapCutaneous5 mg/g
LotionTopical.1 g/100g
EmulsionTopical0.55 %
CreamTopical.28 mg/40mL
KitTopical
CreamTopical1 %
ConcentrateTopical.22 g/45mL
LiquidTopical.075 g/15mL
LiquidTopical.002 mg/mL
CreamTopical.000003 g/30mL
Kit
CreamTopical.002 g/g
LiquidTopical5 mg/mL
SolutionTopical1.9 mg/380mL
CreamTopical.65 mg/130mL
CreamTopical.15 mg/30mL
CreamTopical.75 mg/150mL
CreamTopical.1 mL/100mL
CreamTopical.0075 g/25g
LiquidTopical.5 g/100mL
LiquidTopical.02 g/4mL
LiquidTopical.625 mg/125mL
PatchTopical
CreamTopical0.51 %
PowderTopical.3 mg/3g
PowderTopical
PowderTopical.003 g/3g
PowderTopical.2 mg/2g
LiquidTopical.001 g/mL
LiquidTopical.1 mg/mL
MouthwashDental
Gel, dentifriceDental
CreamTopical.0005 g/g
PowderTopical.0001 g/g
CreamTopical.425 g/85mL
CreamTopical.02 mg/mL
GelTopical5.5 g/L
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility4.73 mg/mLALOGPS
logP-2ALOGPS
logP-2.4ChemAxon
logS-1.5ALOGPS
pKa (Strongest Acidic)7.95ChemAxon
pKa (Strongest Basic)-3.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area113.32 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity32.02 m3·mol-1ChemAxon
Polarizability12.89 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-0uds-0911000000-d6d990e16a15b9f27262
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-0udi-0920000000-abb5512bfc08cbdd004f
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-0f79-0900000000-bf39d4fc494ccd722796
GC-MS Spectrum - GC-MS (5 TMS)GC-MSsplash10-00kr-4911230000-f2112ac79e45fb821ab6
GC-MS Spectrum - GC-MS (4 TMS)GC-MSsplash10-0f8i-3933100000-45367e01790bfc8afd6e
GC-MS Spectrum - GC-MS (3 TMS)GC-MSsplash10-0zfr-4951100000-88808e71aea4d5ad7885
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - EI-BGC-MSsplash10-0006-9100000000-5f4cd23ea44234e5a455
GC-MS Spectrum - EI-BGC-MSsplash10-0006-9100000000-c9c0d8a7f1e5f105a9c3
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0uds-0911000000-d6d990e16a15b9f27262
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0f79-0900000000-bf39d4fc494ccd722796
GC-MS Spectrum - GC-MSGC-MSsplash10-00kr-4911230000-f2112ac79e45fb821ab6
GC-MS Spectrum - GC-MSGC-MSsplash10-0f8i-3933100000-45367e01790bfc8afd6e
GC-MS Spectrum - GC-MSGC-MSsplash10-0zfr-4951100000-88808e71aea4d5ad7885
Mass Spectrum (Electron Ionization)MSsplash10-0006-9200000000-5ad052308edfab7b8c5f
MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)LC-MS/MSsplash10-02t9-8900000000-bb0a5fee22239a104e6f
MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)LC-MS/MSsplash10-03dj-9000000000-09992debd5f3d399b902
MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)LC-MS/MSsplash10-01oy-9000000000-8fe7df22b2abb81b934a
MS/MS Spectrum - EI-B (Unknown) , PositiveLC-MS/MSsplash10-0006-9100000000-08b1881abaf98821d201
MS/MS Spectrum - EI-B (HITACHI M-60) , PositiveLC-MS/MSsplash10-0006-9100000000-297710f62f9699946151
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-066r-0900000000-4e30eec1c2a8c4cb7fa8
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-5900000000-0e0e6cbea70e14292a57
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-006w-9000000000-d53fc563af9567f05b8a
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-066r-0900000000-4e30eec1c2a8c4cb7fa8
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-5900000000-0e0e6cbea70e14292a57
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-006w-9000000000-d53fc563af9567f05b8a
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-066r-0900000000-4e30eec1c2a8c4cb7fa8
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-5900000000-0e0e6cbea70e14292a57
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-006w-9000000000-d53fc563af9567f05b8a
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-066r-0900000000-4e30eec1c2a8c4cb7fa8
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-5900000000-0e0e6cbea70e14292a57
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-006w-9000000000-d53fc563af9567f05b8a
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-03k9-9600000000-775f532f9c5d9acd1ee6
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-01vo-9400000000-a4e69e926b530e953cc3
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-4c973a5209a8104a49e3
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-03k9-9600000000-775f532f9c5d9acd1ee6
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-01vo-9400000000-a4e69e926b530e953cc3
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-4c973a5209a8104a49e3
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-03k9-9600000000-775f532f9c5d9acd1ee6
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-01vo-9400000000-a4e69e926b530e953cc3
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-4c973a5209a8104a49e3
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-03k9-9600000000-775f532f9c5d9acd1ee6
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-01vo-9400000000-a4e69e926b530e953cc3
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-4c973a5209a8104a49e3
MS/MS Spectrum - DI-ESI-qTof , PositiveLC-MS/MSNot Available
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0006-3900000000-4522c35cdff00863fb30
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-0006-3900000000-958f71dbb6c860bba8ce
MS/MS Spectrum - , negativeLC-MS/MSsplash10-01ot-7900000000-496295ec2eda1d1fe993
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0002-9100000000-8c779bd6b0021171c0c2
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-014i-1900000000-7a7ef98117854df99d9c
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-014i-1900000000-2559050d81e822a0197d
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-000j-1900000000-cba5c4c47b0dac6d035a
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-000i-0900000000-cca693ae9b6a97cf20d6
13C NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable

Taxonomy

Classification
Not classified

Drug created on December 03, 2015 09:51 / Updated on May 21, 2018 17:38